Surfactant protein A and surfactant protein D variation in pulmonary disease

• Published in: Immunobiology (1979) 2007-01, Vol.212 (4), p.381-416
• Main Authors: Sorensen, Grith Lykke, Husby, Steffen, Holmskov, Uffe
• Format: Article
• Language: English
• Subjects: Advanced Basic Science; Allergy and Immunology; Animals; Gene Expression Regulation; Humans; Immunity, Innate - immunology; Inflammation; Innate immunity; Lung Diseases - genetics; Lung Diseases - immunology; Lung Diseases - metabolism; Lung Diseases - pathology; Phospholipid homoeostasis; Polymorphism, Genetic - genetics; Pulmonary diseases; Pulmonary Surfactant-Associated Protein A - chemistry; Pulmonary Surfactant-Associated Protein A - genetics; Pulmonary Surfactant-Associated Protein A - immunology; Pulmonary Surfactant-Associated Protein A - metabolism; Pulmonary Surfactant-Associated Protein D - chemistry; Pulmonary Surfactant-Associated Protein D - genetics; Pulmonary Surfactant-Associated Protein D - immunology; Pulmonary Surfactant-Associated Protein D - metabolism; Surfactant proteins A and D
• ISSN: 0171-2985; 1878-3279
• DOI: 10.1016/j.imbio.2007.01.003

Abstract Surfactant proteins A (SP-A) and D (SP-D) have been implicated in pulmonary innate immunity. The proteins are host defense lectins, belonging to the collectin family which also includes mannan-binding lectin (MBL). SP-A and SP-D are pattern-recognition molecules with the lectin domains binding preferentially to sugars on a broad spectrum of pathogen surfaces and thereby facilitating immune functions including viral neutralization, clearance of bacteria, fungi and apoptotic and necrotic cells, modulation of allergic reactions, and resolution of inflammation. SP-A and SP-D can interact with receptor molecules present on immune cells leading to enhanced microbial clearance and modulation of inflammation. SP-A and SP-D also modulate the functions of cells of the adaptive immune system including dendritic cells and T cells. Studies on SP-A and SP-D polymorphisms and protein levels in bronchoalveolar lavage and blood have indicated associations with a multitude of pulmonary inflammatory diseases. In addition, accumulating evidence in mouse models of infection and inflammation indicates that recombinant forms of the surfactant proteins are biologically active in vivo and may have therapeutic potential in controlling pulmonary inflammatory disease. The presence of the surfactant collectins, especially SP-D, in non-pulmonary tissues, such as the gastrointestinal tract and genital organs, suggest additional actions located to other mucosal surfaces. The aim of this review is to summarize studies on genetic polymorphisms, structural variants, and serum levels of human SP-A and SP-D and their associations with human pulmonary disease.